|
|
|
Nabi and GlaxoSmithKline to Develop Anti-Smoking Vaccine
November 16, 2009
Nabi Biopharmaceuticals is partnering with GlaxoSmithKline to develop an anti-smoking vaccine. Nabi is developing NicVAX, a vaccine whose intent it is to train the immune system to produce antibodies that attach themselves to nicotine.
Copyright (2009) Market News Video.
|
|
|